Prostaglandin E₂ regulates renal function in C57/BL6 mouse with 5/6 nephrectomy

Area of Science:

• Nephrology
• Vascular Biology
• Biochemistry

Background:

• Chronic renal failure (CRF) impacts renal hemodynamics and vascular function.
• Cyclooxygenases (COX) and their metabolites play a role in regulating vascular tone.
• Understanding these roles is crucial for managing CRF progression.

Purpose of the Study:

• To investigate the roles of cyclooxygenases (COX) and their metabolites in a mouse model of chronic renal failure (5/6 nephrectomy).
• To assess the impact on renal vascular responsiveness and function.

Main Methods:

• Utilized a 5/6 nephrectomy (5/6Nx) mouse model, comparing it to sham-operated (2K) and one kidney removal (1K) groups.
• Measured renal resistive index via ultrasonography.
• Analyzed renal function, vascular responsiveness, and protein expression (eNOS, COX-2) using Western blotting, immunohistochemistry, and ELISAs.

Main Results:

• Acetylcholine-induced relaxations were impaired in renal arteries of 1K and 5/6Nx mice.
• Indomethacin (COX inhibitor) improved responses in 5/6Nx mice.
• 5/6Nx mice showed decreased eNOS and increased COX-2, prostacyclin, and thromboxane A2 in renal arteries, alongside reduced microvascular resistance.

Conclusions:

• Early renal mass reduction leads to renal arterial constriction via eNOS downregulation and COX-2 upregulation.
• Increased prostacyclin and thromboxane A2 contribute to this constriction.
• Reduced prostaglandin E2 in the renal cortex is vital for maintaining renal function in CRF.